Impaired insulin sensitivity is considered an important risk factor for atherosclerotic disease [37–39], and a key determinant of cardiovascular risk factors, including visceral obesity, atherogenic dyslipidemia, and hypertension, clustering within the metabolic syndrome [40]. Here, INS is linked to metabolic syndrome.